세계의 담낭암 시장 : 치료 유형별, 암 유형별, 유통 채널별, 지역별
Gallbladder Cancer Market, By Treatment Type, By Cancer Type, By Distribution Channel, By Geography
상품코드
:
1391921
리서치사
:
Coherent Market Insights
발행일
:
2023년 11월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 담낭암(Gallbladder Cancer) 시장 규모는 2023년 7,350만 달러에서 2030년 1억 10만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR은 4.5%로 추이하며 성장 할 것으로 예상됩니다.
| 보고서 대상 범위 |
보고서 세부정보 |
| 기준연도 |
2022년 |
2023년 시장 규모 |
7,350만 달러 |
| 실적 데이터 |
2018-2021년 |
예측 기간 |
2023-2030년 |
| 예측 기간의 CAGR |
4.50% |
2030년 시장 규모 예측 |
1억 10만 달러 |
그림 1. 담낭암 시장 점유율(%), 지역별(2023년)
담낭암은 비교적 드문 암으로, 노인 여성에게 많이 보입니다. 담낭암은 수술적으로 담낭을 적출하는 것이 불가능하게 된 말기에 발견되는 경우가 많습니다. 담낭은 복부의 오른쪽, 간 바로 아래에있는 작은 배 모양의 장기입니다. 담낭은 간에서 분비되는 소화액인 담즙을 저장합니다. 담낭암의 위험 요인으로는 담석, 담낭 폴립, 만성 담낭염, 특정 유전성 질환 등이 있습니다. 담낭암의 증상으로는 복통, 특히 오른쪽 상복부의 통증, 복부 팽만감, 발열, 의도하지 않은 체중 감소, 메스꺼움, 피부와 눈의 황달 등이 있습니다.
시장 역학 :
담낭암 치료 시장은 앞으로 수년간 큰 성장이 예상됩니다. 주로 신흥국 시장에서 담낭암의 이환율 상승이 시장 성장의 주요 촉진 요인입니다. 또한 진단기술과 치료방법의 진보로 환자의 생존율과 생활의 질이 향상되고 있습니다. 예를 들어 2023년 American Cancer Society가 발표한 데이터에 따르면, 담낭암의 신규 사례는 남성에서 5,750명, 여성에서 6,470명, 총 1만 2,220명입니다.
본 조사의 주요 특징
- 세계의 담낭암 시장을 상세하게 분석하여 2022년을 기준연도로 한 예측기간(2023-2030년) 시장 규모 및 CAGR(%)을 제공합니다.
- 또한 서로 다른 부문에 걸친 잠재적인 수익 성장 기회를 밝히고 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진 요인, 억제 요인, 기회, 신제품 출시와 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁전략 등에 관한 중요한 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 파라미터를 바탕으로 세계의 담낭암 시장에서 주요 기업을 프로파일하고 있습니다.
- 본 조사의 대상이 되는 주요 기업에는 Eli Lilly and Company, Bristol-Myers Squibb, Roche, Pfizer, Novartis, Merck&Co., Inc., Sanofi, AstraZeneca, AbbVie, Gilead Sciences가 포함됩니다.
- 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 미래의 제품 상시, 타이핑, 시장 확대, 마케팅 전술에 관한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계의 담낭암 시장 보고서는 투자자, 공급업체, 제품 제조사, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계의 담낭암 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 인수 및 합병 시나리오
제4장 담낭암 시장-COVID-19 팬데믹의 영향
- COVID-19의 역학
- 공급 및 수요측 분석
- 경제적 영향
제5장 담낭암 시장, 치료 유형별(2018-2030년)
- 개요
- 수술
- 화학요법
- 방사선치료
- 면역요법
- 표적요법
- 기타
제6장 담낭암 시장, 암 유형별(2018-2030년)
- 개요
- 선암암
- 편평상피암
- 선편평상피암
- 소세포암
- 기타
제7장 담낭암 시장, 유통 채널별(2018-2030년)
제8장 담낭암 시장, 지역별(2018-2030년)
- 개요
- 북미
- 미국
- 캐나다
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- ASEAN 국가
- 기타 아시아태평양
- 남미
- 브라질
- 멕시코
- 아르헨티나
- 기타 남미
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제9장 경쟁 구도
- Eli Lilly and Company
- Bristol-Myers Squibb
- Roche
- Pfizer
- Novartis
- Merck&Co., Inc.
- Sanofi
- AstraZeneca
- AbbVie
- Gilead Sciences
제10장 섹션
LYJ
영문 목차
The global gallbladder cancer market size is projected to reach US$ 100.1 million by 2030, from US$ 73.5 million in 2023, at a CAGR of 4.5% during the forecast period.
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 73.5 Mn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
4.50% |
2030 Value Projection: |
US$ 100.1 Mn |
Figure 1. Global Gallbladder Cancer Market Share (%), By Region, 2023
Gallbladder cancer is a relatively rare cancer that is most common in older women. It is often discovered at its late stage, when it is no longer possible to remove the gallbladder surgically. The gallbladder is a small, pear-shaped organ on the right side of the abdomen, just beneath the liver. The gallbladder stores bile, a digestive fluid produced by liver. Risk factors for gallbladder cancer include gallstones, gallbladder polyps, chronic gallbladder inflammation, and certain inherited conditions. Symptoms of gallbladder cancer may include abdominal pain, particularly in the upper right portion of the abdomen, abdominal bloating, fever, unintended weight loss, nausea, and yellowing of the skin and the whites of the eyes (jaundice).
Market Dynamics:
The global market for gallbladder cancer treatment is expected to witness significant growth in the coming years. The rising incidence of gallbladder cancer, primarily in developing countries, is a major driver for market growth. Additionally, advancements in diagnostic techniques and treatment modalities are enhancing the survival rates and quality of life for patients. For instance, according to the data published by the American Cancer Society in , about 12,220 new cases of gallbladder cancer : 5,750 in men and 6,470 in women in 2023.
Key features of the study:
- This report provides an in-depth analysis of the global gallbladder cancer market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global gallbladder cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Eli Lilly and Company, Bristol-Myers Squibb, Roche, Pfizer, Novartis, Merck & Co., Inc., Sanofi, AstraZeneca, AbbVie, and Gilead Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global gallbladder cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gallbladder cancer market
Detailed Segmentation:
- By Treatment Type
- Surgery
- Chemotherapy
- Radiation Therapy
- Immunotherapy
- Targeted Therapy
- Others
- By Cancer Type
- Adenocarcinoma
- Squamous cell carcinoma
- Adenosquamous carcinoma
- Small cell carcinoma
- Undifferentiated carcinoma
- Others
- By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- By Region
- North America
- Europe
- APAC
- Latin America
- Middle East
- Africa
- Top Players Operating in Gallbladder Cancer Market
- Eli Lilly and Company
- Bristol-Myers Squibb
- Roche
- Pfizer
- Novartis
- Merck & Co., Inc.
- Sanofi
- AstraZeneca
- AbbVie
- Gilead Sciences
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Gallbladder Cancer Market, By Treatment Type
- Gallbladder Cancer Market, By Cancer Type
- Gallbladder Cancer Market, By Distribution Channel
- Gallbladder Cancer Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing prevalence of gallbladder cancer
- High cost burden of cancer therapies
- Development of targeted therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Gallbladder Cancer Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Gallbladder Cancer Market, By Treatment Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
6. Gallbladder Cancer Market, By Cancer Type, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Adenocarcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Squamous cell carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Adenosquamous carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Small cell carcinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
7. Gallbladder Cancer Market, By Distribution Channel, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
8. Gallbladder Cancer Market, By Region, 2018-2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2018 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 - 2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2018-2030, (US$ Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
관련자료
